G
Gui-Nan Lin
Researcher at Sun Yat-sen University
Publications - 10
Citations - 379
Gui-Nan Lin is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Hepatitis B virus & HBsAg. The author has an hindex of 8, co-authored 10 publications receiving 337 citations.
Papers
More filters
Journal ArticleDOI
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray.
Jiehua He,Roujun Peng,Zhongyu Yuan,Shusen Wang,Jie-Wen Peng,Gui-Nan Lin,Xiaomei Jiang,Tao Qin +7 more
TL;DR: It is suggested that TNBC may be further divided into two subtypes according to AR status, and androgen receptor (AR) expression was a favorable prognostic factor of DFS and OS in patients with TNBC.
Journal ArticleDOI
Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet
TL;DR: It is implicate that circulating AMC and LMR are regarded as independent prognostic factors for PFS and OS in previously untreated metastatic NSCLC patients receiving platinum-based doublet.
Journal ArticleDOI
Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment.
TL;DR: Elevated neutrophil‐to‐lymphocyte ratio has been demonstrated to be a poor prognostic factor in multiple types of malignancies, whereas the effect of NLR on the prognosis of epidermal growth factor receptor (EGFR)‐mutated advanced non‐small‐cell lung cancer (NSCLC) patients treated with first‐line EGFR tyrosine kinase inhibitors (TKIs) is not fully addressed.
Journal ArticleDOI
Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy
TL;DR: Pre-treatment ALC and LMR were demonstrated to be independent prognostic factors in patient with newly diagnosed metastatic NPC receiving chemotherapy, while AMC did not retained its prognostic significance in COX multivariate analysis.
Journal ArticleDOI
Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
TL;DR: The effect of transcatheter arterial chemoembolization (TACE) therapy on hepatitis B virus reactivation in hepatocellular carcinoma patients with prior resolved hepatitis B is not fully understood.